+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bioinformatics Global Market Report 2022, By Products and Services, By Application, By End Users

  • ID: 5544323
  • Report
  • February 2022
  • Region: Global
  • 175 Pages
  • The Business Research Company

FEATURED COMPANIES

  • Accelrys
  • Biomax Informatix
  • DNASTAR
  • Illumina
  • PerkinElmer
  • Quest Diagnostics
Bioinformatics Global Market Report 2022 provides strategists, marketers and senior management with the critical information they need to assess the global bioinformatics market.



The report focuses on the bioinformatics market which is experiencing strong growth.
  • The report gives a guide to the bioinformatics market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic

    Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for the bioinformatics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Bioinformatics Market Global Report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
  • It traces the market’s historic and forecast market growth by geography.
  • The Market Characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies.
  • Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope


Markets Covered:
1) By Products and Services: Knowledge Management Tools; Data Analysis Platforms; Services
2) By Application: Metabolomics; Molecular Phylogenetics; Transcriptomics; Proteomics; Chemoinformatics; Genomics; Others
3) By End Users: Pharmaceutics; Animal Study; Agriculture; Forensic Science; Other End Users

Companies Mentioned: Agilent Technologies; Illumina; QIAGEN; Affymetrix; Thermo Fisher Scientific

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Bioinformatics Market

What is the estimated value of the Global Bioinformatics Market?

The Global Bioinformatics Market was estimated to be valued at $13.0 billion in 2022.

What is the growth rate of the Global Bioinformatics Market?

The growth rate of the Global Bioinformatics Market is 13.1%, with an estimated value of $21.3 billion by 2026.

What is the forecasted size of the Global Bioinformatics Market?

The Global Bioinformatics Market is estimated to be worth $21.3 billion by 2026.

Who are the key companies in the Global Bioinformatics Market?

Key companies in the Global Bioinformatics Market include Agilent Technologies, Illumina, QIAGEN, Affymetrix, Thermo Fisher Scientific, BGI, Dassault Systems, Eurofins scientific and Biomax Informatix.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accelrys
  • Biomax Informatix
  • DNASTAR
  • Illumina
  • PerkinElmer
  • Quest Diagnostics

1. Executive Summary2. Bioinformatics Market Characteristics3. Bioinformatics Market Trends And Strategies4. Impact Of COVID-19 On Bioinformatics
5. Bioinformatics Market Size And Growth
5.1. Global Bioinformatics Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Bioinformatics Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Bioinformatics Market Segmentation
6.1. Global Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Knowledge Management Tools
Data Analysis Platforms
Services
6.2. Global Bioinformatics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Metabolomics
Molecular Phylogenetics
Transcriptomics
Proteomics
Chemoinformatics
Genomics
Others
6.3. Global Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Pharmaceutics
Animal Study
Agriculture
Forensic Science
Other end users
7. Bioinformatics Market Regional And Country Analysis
7.1. Global Bioinformatics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Bioinformatics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Bioinformatics Market
8.1. Asia-Pacific Bioinformatics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Bioinformatics Market
9.1. China Bioinformatics Market Overview
9.2. China Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Bioinformatics Market
10.1. India Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Bioinformatics Market
11.1. Japan Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Bioinformatics Market
12.1. Australia Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Bioinformatics Market
13.1. Indonesia Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Bioinformatics Market
14.1. South Korea Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Bioinformatics Market
15.1. Western Europe Bioinformatics Market Overview
15.2. Western Europe Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Bioinformatics Market
16.1. UK Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Bioinformatics Market
17.1. Germany Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Bioinformatics Market
18.4. France Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Bioinformatics Market
19.1. Eastern Europe Bioinformatics Market Overview
19.2. Eastern Europe Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Bioinformatics Market
20.1. Russia Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Bioinformatics Market
21.1. North America Bioinformatics Market Overview
21.2. North America Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Bioinformatics Market
22.1. USA Bioinformatics Market Overview
22.2. USA Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Bioinformatics Market
23.1. South America Bioinformatics Market Overview
23.2. South America Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Bioinformatics Market
24.1. Brazil Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Bioinformatics Market
25.1. Middle East Bioinformatics Market Overview
25.2. Middle East Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Bioinformatics Market
26.1. Africa Bioinformatics Market Overview
26.2. Africa Bioinformatics Market, Segmentation By Products and Services, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Bioinformatics Market, Segmentation By End Users, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Bioinformatics Market Competitive Landscape And Company Profiles
27.1. Bioinformatics Market Competitive Landscape
27.2. Bioinformatics Market Company Profiles
27.2.1. Agilent Technologies
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Illumina
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. QIAGEN
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Affymetrix
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Thermo Fisher Scientific
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Bioinformatics Market29. Bioinformatics Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Research Inquiries
30.4. About the Publisher
30.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accelrys
  • Biomax Informatix
  • DNASTAR
  • Illumina
  • PerkinElmer
  • Quest Diagnostics
Major players in the bioinformatics market are Agilent Technologies, Illumina, QIAGEN, Affymetrix, Thermo Fisher Scientific, BGI, Dassault Systems, Eurofins scientific, Bruker Daltonics, Biomax Informatix, DNASTAR, Partek, Geneva Bioinformatics, Perkinelmer Inc., Accelrys, SA Nonlinear Dynamics, Quest Diagnostics, Sophia Genetics, Waters Corporation, Permin Elmer Inc., Applied Biologicals Materials., Life Technologies, PerkinElmer, Waters Corporation, Sophia Genetics, Celera, Tripos, LP, Helicos Biosciences Incorporation and IBM Life Sciences.

The global bioinformatics market is expected to grow from $11.55 billion in 2021 to $13.02 billion in 2022 at a compound annual growth rate (CAGR) of 12.7%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $21.32 billion in 2026 at a CAGR of 13.1%.

The bioinformatics market consists of sales of bioinformatics and related services. Bioinformatics combines computer programming, information engineering, mathematics, and statistics to analyze biological data for drug discovery and for preclinical studies.

The main product and service types of bioinformatics are knowledge management tools, data analysis platforms, and services. Knowledge management tools are technologies used by organizations to share information both internally and externally. The various applications include metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics, genomics, others that are used by pharmaceutics, animal study, agriculture, forensic science, and other end users.

Increasing demand for protein sequencing is driving growth in the bioinformatics market. Protein sequencing refers to the process of determining the sequence of amino acids in all or part of the proteins present in DNA, based on which specific functions, activities, origin or localization of the protein is determined. Protein sequencing helps analysts to understand the distribution of amino acids along the sequences and the structure of proteins. With bioinformatics methods and databases, capacity, structure and developmental history of proteins can be effectively identified. The demand for protein sequencing is expected to grow on account of factors such as advancements in clinical mass spectrometry and analytical techniques, and significant adoption of target-based drug development by pharmaceutical and biotechnology companies. For instance, in 2021, the total number of protein sequences in UniProtKB, which is a freely accessible database of protein sequence and functional information, increased to approximately 190 million.

Lack of interoperability among various available data formats is acting as a restraint on the bioinformatics market. Various data formats come with differences in structures of data. There are numerous protein databases available through various resources, and each database chooses to represent proteins in a different format. Also, different data models such as object data model or relational data model are used while collecting data. Therefore, the problem of interoperability arises when a researcher tries to integrate the results of unique databases present in different data formats. Various data formats available for bioinformatics include Compressed Row Storage (CRS), Sparse Vector, Avro, Parquet and ORC (Optimized Row Compressed). According to a report by Pharmaphorum, an estimated 80% of the researchers’ time is spent on data grooming and only 20% on actual data analysis. This is essentially due to the lack of standardized file types and inconsistent data formatting, which means that every new program results in a new data format. The interoperability issues arising from the use of multiple data formats is affecting market growth.

Companies in the bioinformatics market are increasingly investing in the research and development of nanopore sequncing technology. Nanopore sequencing is a single molecule DNA sequencing technology which eliminates the need for Polymerase Chain Reaction or chemical labelling of the sample. This technology passes ionic current through nanopores (a pore of nanometer size) and when the biological molecules pass through the nanopores or near to it then this technology measures the changes in current which can be used to identify the molecule. Nanopore sequencing technology offers high throughput, low cost, longer reads (Sequence of a section of a unique fragment) to the analyst and helps in the collection of data which is an essential part of bioinformatics. For instance, in 2020, Oxford Nanopore Technologies raised $109.5 million to support the ramp of commercial and manufacturing operations and to further develop its nanopore technology.

The bioinformatics market is governed by various regulatory bodies for quality and compliance of bioinformatics platforms. For instance, in India, the Biotechnology Industry Research Assistance Council (BIRAC), set up by Department of Biotechnology (DBT), Government of India, regulates the bioinformatics market. BIRAC introduces Technology Readiness Levels (TRLs) as a measure of estimating the maturity of technology while in the evaluation phases until these technologies are complete to be offered commercially. The TRL scale provides 9 technology readiness levels with TRL1 being the stage when the technology is ideated, and TRL9 being the stage when the technology is ready for commercial use. The manufacturers have to get past TRL9 to have their product available commercially and ready to be marketed. These TRL's consist of various levels of compliance and processes that the manufacturers must adhere to. The bioinformatics platform is evaluated for quality, feasibility, data privacy and protection as per international standards.

In September 2020, APIS Assay Technologies Ltd, a UK based Biotechnology company acquired BeoGenomics for an undisclosed amount. With the addition of Beogenomics’ proven expertise in bioinformatics APIS Assay Technologies Ltd can more effectively capture the exciting opportunities presented in the bioinformatics space. BeoGenomics, a USA based bioinformatics company that focuses on NGS, SNP chip and GeneChip genomic data processing and analysis.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bioinformatics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Agilent Technologies
  • Illumina
  • QIAGEN
  • Affymetrix
  • Thermo Fisher Scientific
  • BGI
  • Dassault Systems
  • Eurofins scientific
  • Bruker Daltonics
  • Biomax Informatix
  • DNASTAR
  • Partek
  • Geneva Bioinformatics
  • Perkinelmer Inc.
  • Accelrys
  • SA Nonlinear Dynamics
  • Quest Diagnostics
  • Sophia Genetics
  • Waters Corporation
  • Permin Elmer Inc.
  • Applied Biologicals Materials
  • Life Technologies
  • PerkinElmer
  • Waters Corporation
  • Sophia Genetics
  • Celera
  • Tripos
  • LP
  • Helicos Biosciences Incorporation
  • IBM Life Sciences
Note: Product cover images may vary from those shown

Loading
LOADING...